Improving access to specialist care for patients with COPD and asthma
Official title: Pulmonary Specialist-Health Coach Consult (PuSHCon) model to improve access to specialist consultation and receipt of recommended evidence-based care for vulnerable patients with COPD and asthma
Funded at University of California, San Francisco · NIH-10451757 · Data updated 2026-11-12
This study is testing a new way to help people with COPD and asthma get better care by connecting them with lung specialists through health coaches, so they can receive helpful advice without having to go to the hospital.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 1, 2019 |
| Project end | July 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $748,748 |
| NIH project number | 5R01HL143366-04 |
| Project ID | NIH-10451757 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with chronic obstructive pulmonary disease (COPD) or asthma who are receiving care at federally qualified health centers.
✕Less likely to help
Patients with mild respiratory conditions or those not receiving care at federally qualified health centers may not benefit from this research.
What this research studies
This research investigates a new model called PuSHCon, which connects patients with chronic obstructive pulmonary disease (COPD) and asthma to pulmonary specialists through health coaches. These health coaches gather important information from patients at their local clinics and relay it to specialists, who can then provide recommendations without needing the patient to visit the hospital. This approach aims to enhance access to evidence-based care and ensure that patients receive the necessary support to implement these recommendations effectively.
Why it matters
Potential benefit: If successful, this research could significantly improve access to specialized care and treatment for patients with COPD and asthma, leading to better health outcomes.
How similar studies have gone: Other research has shown success with similar health coaching models in improving access to care and patient outcomes, indicating that this approach has potential.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Willard-Grace, Rachel — University of California, San Francisco
- Study coordinator: Willard-Grace, Rachel
Related research
Other NIH-funded projects on the same topics.
-
Pennsylvania asthma-COPD syndromic surveillance for cleaner air and healthier kids
A Pennsylvanian health project is building a real-time warning system to help doctors and families spot spikes in asthma and COPD risks related to air pollution and smoke.
-
How climate change affects respiratory health in asthma and COPD patients
This study, led by Dr. Nicholas Nassikas, is looking at how changes in weather, like temperature and rainfall, affect the breathing health of people with asthma and COPD, especially in Black and Latinx communities, to find ways to help them feel better as our climate changes.
-
Understanding the link between asthma and COPD using advanced data analysis
This study is looking at how asthma and COPD are related, especially how things like being exposed to smoke before birth can affect lung health throughout life, and it's for anyone interested in understanding the biological factors that might influence these breathing conditions.
-
Investigating how genetics and ancestry affect asthma and COPD treatment responses
This study is looking at how your unique genes and background might affect how well asthma and COPD medications work for you, and it invites patients to share their genetic information to help find out more about this connection.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.